ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKETS

 "ANTIMICROBIAL RESISTANCE DIAGNOSTIC MARKETS, STRATEGIES AND TRENDS BY PATHOGEN AND TECHNOLOGY, WITH EXECUTIVE GUIDES. 2023 TO 2027”

“Will Diagnostics solve the problem?  Multiple diagnostic technologies create new global race.”

  PAGES: 360

 Diagnostics are leading the charge in reducing the threat posed by antimicrobial resistance.  Will these technologies solve the problem before new antibiotics come along? New diagnostic technologies, beyond gene sequencing, are under development to capture this growing market.  We have looked at the technology picture, giving you plain language understanding of the different ways pathogens, and infections, can be diagnosed. We have identified the 6 Key Large Pathogen Opportunities in this space and developed market forecasts.   We profile over 30 companies, large and small, working in this area.

Our research makes you the expert in your organization. Get our research team working for you by ordering all, or a portion, of this comprehensive report.  Your credit card order sends the report to your inbox instantly.  Check all your licensing options but don't worry, your order is available as a credit if you wish to upgrade to more information. We wrote this report and we are ready, by phone or email, to help you use it. As always, assistance, and additional specific data, is provided without additional charges. 

All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data.  

See the Table of Contents.

Send an email to us at service@howesoundresearch.com and we will happily email you a FREE copy of SAMPLE PAGES FROM THIS REPORT without any obligation on your part. 

Make investment decisions and valuations with confidence using the latest data.  

ABOUT THE LEAD AUTHOR

Mr. Greg Powell, B.SC., M.B.A is the President of Howe Sound Research and a member of the American Association for Clinical Chemistry. 

He is an experienced business and clinical professional.  He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping."  He has worked in laboratory testing and management for over 20 years.  Mr. Powell’s education includes:

B.Sc. (Chemistry) University of BC

M.B.A. (Finance and Policy) University of BC

Market Research  - Burke Institute

Finance for Senior Executives - Harvard Business School